相关实验视频

Updated: Jul 8, 2025

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

616

在Pembrolizumab引入后两年多的时间内出现细胞因子释放综合征

Kazuhisa Nakashima1, Kashu Kitani1, Kento Kono1

  • 1Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Japan.

Internal medicine (Tokyo, Japan)
|December 17, 2023
PubMed
概括

细胞因子释放综合征 (CRS) 可以在免疫检查点抑制剂治疗肺癌后很长时间表现出来. 这一案例凸显了考虑CRS的重要性,即使感染原因不清楚.

关键词:
细胞因子释放综合征 细胞因子释放综合征免疫检查点抑制剂免疫检查点抑制剂与免疫相关的不良事件其他非小细胞肺癌.这就是Pembrolizumab.

更多相关视频

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.6K
Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

45.1K

相关概念视频